Home LiteratureArticle Details
PMID: 16877362 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

The American journal of pathology ·Vol. 169 ·No. 2 ·2006-08-00 ·Pages 643-54

Marcellini M, De Luca N, Riccioni T, Ciucci A, Orecchia A, Lacal PM, Ruffini F, Pesce M, Cianfarani F, Zambruno G, Orlandi A, Failla CM

Abstract

Placenta growth factor (PlGF), a member of the vascular endothelial growth factor family, plays an important role in adult pathological angiogenesis. To further investigate PlGF functions in tumor growth and metastasis formation, we used transgenic mice overexpressing PlGF in the skin under the control of the keratin 14 promoter. These animals showed a hypervascularized phenotype of the skin and increased levels of circulating PlGF with respect to their wild-type littermates. Transgenic mice and controls were inoculated intradermally with B16-BL6 melanoma cells. The tumor growth rate was fivefold increased in transgenic animals compared to wild-type mice, in the presence of a similar percentage of tumor necrotic tissue. Tumor vessel area was increased in transgenic mice as compared to controls. Augmented mobilization of endothelial and hematopoietic stem cells from the bone marrow was observed in transgenic animals, possibly contributing to tumor vascularization. The number and size of pulmonary metastases were significantly higher in transgenic mice compared to wild-type littermates. Finally, PlGF promoted tumor cell invasion of the extracellular matrix and increased the activity of selected matrix metalloproteinases. These findings indicate that PlGF, in addition to enhancing tumor angiogenesis and favoring tumor growth, may directly influence melanoma dissemination.

MeSH Terms
Animals Cell Movement Cells, Cultured Dose-Response Relationship, Drug Gene Expression Gene Expression Regulation, Neoplastic Hematopoietic Stem Cells/cytology Humans Matrix Metalloproteinase 1/genetics Matrix Metalloproteinase 9/genetics Melanoma/blood supply,genetics,pathology Mice Mice, Transgenic Necrosis Neoplasm Invasiveness Neoplasm Metastasis/pathology Neovascularization, Pathologic Placenta Growth Factor Pregnancy Proteins/genetics RNA, Messenger/genetics,metabolism Tumor Cells, Cultured
Chemicals
PGF protein, human Pgf protein, mouse Pregnancy Proteins RNA, Messenger Placenta Growth Factor Matrix Metalloproteinase 9 Matrix Metalloproteinase 1
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Marcellini Marcella
Laboratory of Experimental Angiogenesis, Sigma Tau, Rome, Italy.
De Luca Naomi
Riccioni Teresa
Ciucci Alessandro
Orecchia Angela
Lacal Pedro Miguel
Ruffini Federica
Pesce Maurizio
Cianfarani Francesca
Zambruno Giovanna
Orlandi Augusto
Failla Cristina Maria
References (42)
42 references, click to expand
  1. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment.
    Am J Pathol. 2004 Feb;164(2):457-66 PMID: 14742252
  2. SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.
    Cancer Lett. 2006 May 8;236(1):39-45 PMID: 15967572
  3. Culture of vascular endothelium.
    Prog Hemost Thromb. 1976;3:1-28 PMID: 181786
  4. The biology of VEGF and its receptors.
    Nat Med. 2003 Jun;9(6):669-76 PMID: 12778165
  5. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.
    Nat Med. 2003 Jul;9(7):936-43 PMID: 12796773
  6. VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis.
    Trends Cardiovasc Med. 2003 Jul;13(5):169-75 PMID: 12837578
  7. Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR.
    J Cancer Res Clin Oncol. 1999 Nov;125(11):621-9 PMID: 10541969
  8. Placenta growth factor is induced in human keratinocytes during wound healing.
    J Invest Dermatol. 2000 Sep;115(3):388-95 PMID: 10951273
  9. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.
    J Invest Dermatol. 2000 Dec;115(6):1000-7 PMID: 11121133
  10. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Nat Med. 2001 May;7(5):575-83 PMID: 11329059
  11. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.
    Ann N Y Acad Sci. 2001 Jun;938:36-45; discussion 45-7 PMID: 11458524
  12. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.
    Nat Med. 2001 Nov;7(11):1194-201 PMID: 11689883
  13. Placental growth factor is a survival factor for tumor endothelial cells and macrophages.
    Cancer Res. 2002 May 15;62(10):2749-52 PMID: 12019148
  14. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.
    J Cell Sci. 2002 Jun 15;115(Pt 12):2559-67 PMID: 12045226
  15. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
    Cancer Cell. 2002 Feb;1(1):99-108 PMID: 12086892
  16. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
    Nat Med. 2002 Aug;8(8):831-40 PMID: 12091877
  17. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.
    Nat Med. 2002 Aug;8(8):841-9 PMID: 12091880
  18. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice.
    J Natl Cancer Inst. 2002 Aug 7;94(15):1134-42 PMID: 12165638
  19. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis.
    Cancer Cell. 2002 Oct;2(4):289-300 PMID: 12398893
  20. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
    Int J Cancer. 2003 Jun 10;105(2):158-64 PMID: 12673673
  21. Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin.
    J Cell Sci. 2003 Sep 1;116(Pt 17):3479-89 PMID: 12865438
  22. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
    Cancer Res. 2003 Dec 1;63(23):8221-5 PMID: 14678978
  23. Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids comprising the N-telopeptide region of a pro-alpha 2(I) chain.
    J Biol Chem. 1987 Dec 5;262(34):16376-85 PMID: 3680255
  24. New colorimetric cytotoxicity assay for anticancer-drug screening.
    J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12 PMID: 2359136
  25. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors.
    Biochem Biophys Res Commun. 1993 Feb 15;190(3):702-8 PMID: 8439321
  26. Vascular endothelial growth factor and its receptors.
    Prog Growth Factor Res. 1994;5(1):89-97 PMID: 7515293
  27. Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.
    J Biol Chem. 1995 Mar 31;270(13):7717-23 PMID: 7706320
  28. Endothelial cell-to-cell junctions.
    FASEB J. 1995 Jul;9(10):910-8 PMID: 7615160
  29. Angiogenesis in cancer, vascular, rheumatoid and other disease.
    Nat Med. 1995 Jan;1(1):27-31 PMID: 7584949
  30. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
    J Biol Chem. 1996 Jul 26;271(30):17629-34 PMID: 8663424
  31. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor.
    J Clin Invest. 1996 Dec 1;98(11):2507-11 PMID: 8958213
  32. Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma.
    Eur J Gynaecol Oncol. 1997;18(6):508-10 PMID: 9443023
  33. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
    Cancer Res. 1998 Mar 1;58(5):1048-51 PMID: 9500469
  34. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
    Am J Pathol. 1999 May;154(5):1381-90 PMID: 10329591
  35. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
    Science. 1999 Jun 18;284(5422):1994-8 PMID: 10373119
  36. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.
    J Pathol. 1999 Sep;189(1):66-71 PMID: 10451490
  37. Vascularization of melanoma by mobilization and remodeling of preexisting latent vessels to patency.
    Cancer Res. 2005 Feb 1;65(3):913-8 PMID: 15705890
  38. Metalloproteinases and their inhibitors in tumor angiogenesis.
    Int J Cancer. 2005 Jul 20;115(6):849-60 PMID: 15729716
  39. An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.
    Int J Oncol. 2005 Dec;27(6):1625-32 PMID: 16273219
  40. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.
    Nature. 2005 Dec 8;438(7069):820-7 PMID: 16341007
  41. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells.
    Cell. 2006 Jan 13;124(1):175-89 PMID: 16413490
  42. Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation.
    Blood. 2004 Apr 15;103(8):2942-9 PMID: 15070669
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
2006-08-00
Pages
643-54
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1698793
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com